While collecting a blood sample, the patient slumps over in the phlebotomy chair. Which of the following actions should the phlebotomist take first?

Choice A reason:
The order of citrate, heparin, EDTA, and fluoride is not the correct sequence for blood collection. The correct order is essential to prevent cross-contamination of additives between tubes, which could interfere with test results. Citrate tubes should be drawn first to ensure that the blood does not clot prematurely, but heparin should not follow immediately after citrate.

Choice B reason:
Citrate tubes, which contain sodium citrate, are used for coagulation tests and must be drawn first to ensure the proper blood-to-additive ratio. EDTA tubes are drawn next because EDTA binds calcium and prevents clotting, making it ideal for complete blood counts and other hematology studies. Heparin tubes, which prevent clotting by inhibiting thrombin and thromboplastin, are drawn after EDTA. Lastly, fluoride tubes, which contain a glycolysis inhibitor, are drawn to preserve glucose levels and are typically used for glucose and lactate testing.

Choice C reason:
Starting with fluoride is not recommended as it could lead to contamination of the EDTA and heparin tubes with fluoride, which could affect the results of certain tests, such as calcium determinations in heparin tubes. The order of draw is designed to minimize such risks.

Choice D reason:
This sequence is incorrect because fluoride tubes are not drawn before EDTA and heparin tubes. The presence of fluoride could potentially contaminate the subsequent tubes and alter the results of the tests that require heparin or EDTA as an anticoagulant.

In phlebotomy, following the correct order of draw is crucial. The order is established based on the type of additive in each tube and its potential to interfere with tests conducted in subsequent tubes. The standard order is: blood cultures, citrate tubes, serum tubes with or without clot activator and gel, heparin tubes with or without gel, EDTA tubes, and lastly, fluoride tubes. This sequence helps prevent cross-contamination and ensures the accuracy of laboratory results, which are critical for patient diagnosis and treatment.

Choice A reason:
Quality control measurements are essential for ensuring the accuracy and reliability of blood glucose monitors. According to best practices, all blood glucose monitors in use, regardless of their origin, should undergo daily quality control checks. This is to verify that the monitors are functioning correctly and providing accurate readings, which is crucial for patient care and treatment decisions.

Choice B reason:
Focusing only on the blood glucose monitors from the new office for daily quality control measurements is not sufficient. While new equipment may be less likely to have wear-and-tear issues that could affect performance, it is still subject to potential inaccuracies and must be included in the daily quality control routine.

Choice C reason:
Similarly, excluding the new monitors and only checking those from the old medical office would neglect the possibility of inaccuracies in the newer equipment. All monitors, irrespective of their age, can experience calibration drift or other issues that affect their performance.

Choice D reason:
Opting not to perform daily quality control measurements on any of the blood glucose monitors would be against the recommended guidelines and could lead to inaccurate blood glucose readings. This could have serious implications for patient health, particularly in the management of diabetes.